九洲药业(603456) - 2018 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders decreased by 16.83% to CNY 94,745,282.25 compared to the same period last year[5] - Operating income for the period was CNY 1,268,938,061.53, reflecting a growth of 2.81% year-on-year[5] - The weighted average return on equity decreased by 0.80 percentage points to 3.58%[5] - Basic earnings per share decreased by 14.29% to CNY 0.12[5] - The company reported a non-operating loss of CNY 14,354,552.19 for the period[6] - The net profit after deducting non-recurring gains and losses was CNY 121,352,873.68, an increase of 13.55% year-on-year[5] - Total operating revenue for the third quarter was RMB 349,314,038.10, a decrease of 20% compared to RMB 435,945,884.04 in the same period last year[24] - Net profit for the third quarter was RMB 5,682,022.71, a decline of 86.9% from RMB 40,308,243.40 in the previous year[26] - The company reported a total profit of RMB 9,085,313.71 for the third quarter, down 81.2% from RMB 48,248,294.24 year-on-year[26] - The total comprehensive income for the third quarter was RMB 6,516,382.80, a decrease of 83.5% from RMB 39,533,701.26 in the same period last year[27] - Basic earnings per share for the third quarter were RMB 0.01, down from RMB 0.05 in the previous year[27] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 3,189,607,340.74, an increase of 1.50% compared to the end of the previous year[5] - The company’s total assets amounted to ¥3,189,607,340.74, with current assets totaling ¥1,391,460,783.02[18] - The company’s total liabilities reached ¥1,390,000,000.00, indicating a significant increase in financial obligations[18] - Total liabilities increased to ¥491,074,837.05 from ¥461,771,345.50, reflecting a growth of about 6.3%[19] - Shareholders' equity totaled ¥2,698,532,503.69, up from ¥2,680,740,523.07, indicating a growth of approximately 0.7%[20] - The company reported a decrease in unallocated profits to ¥633,691,365.61 from ¥694,946,563.27, a decline of about 8.8%[23] Cash Flow - Net cash flow from operating activities increased by 29.61% to CNY 219,091,213.23 compared to the same period last year[5] - Net cash flow from investing activities decreased by 58.90% to -¥200,478,409.80, mainly due to increased purchases of financial products[13] - Net cash flow from financing activities dropped by 731.35% to -¥68,984,652.31, attributed to reduced equity incentive funds received[14] - Cash flow from operating activities for the first nine months of 2018 was CNY 219,091,213.23, an increase from CNY 169,036,868.33 in the previous year[32] - Cash flow from investing activities showed a net outflow of CNY 200,478,409.80 for the first nine months of 2018, compared to a net outflow of CNY 126,163,845.35 in the previous year[33] - Cash flow from financing activities resulted in a net outflow of CNY 68,984,652.31 in the first nine months of 2018, contrasting with a net inflow of CNY 10,926,489.85 in the same period last year[33] Shareholder Information - The total number of shareholders at the end of the reporting period was 24,473[9] - The largest shareholder, Zhejiang Zhongbei Jiuzhou Group Co., Ltd., holds 39.60% of the shares, with 319,171,824 shares pledged[10] - The chairman, Hua Lirong, has increased her shareholding by acquiring 7,374,760 shares, representing 0.92% of the total share capital[14] Current Assets and Liabilities - Current liabilities rose to ¥425,445,110.94 compared to ¥407,956,104.84, an increase of about 4.5%[19] - The company’s cash and cash equivalents decreased to ¥177,593,309.81 from ¥268,418,154.29, a decline of approximately 33.8%[21] - Accounts receivable increased to ¥211,037,389.49 from ¥201,699,300.96, showing a growth of about 4.6%[21] - Inventory levels rose to ¥189,471,150.47 from ¥183,445,301.90, an increase of approximately 3.1%[22] Deferred Items - Deferred tax assets rose by 100.89% to ¥8,779,412.09 due to losses recognized from foreign exchange forward contracts[11] - Deferred income increased to ¥58,994,942.04 from ¥53,815,240.66, reflecting a growth of approximately 9.5%[19]